Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 380 is a non-coding pseudogene closely related to the functional 5S ribosomal RNA gene. Pseudogenes of ribosomal RNA typically arise from duplication or retrotransposition events. Unlike the functional 5S rRNA, which forms an essential structural component of the ribosome and participates in protein synthesis[1][3][5][7], this pseudogene does not encode a functional RNA molecule and does not participate in ribosome biogenesis or other cellular processes. Some ribosomal pseudogenes may be transcribed, but they generally lack regulatory conservation and do not produce active products[2][8]. There is no evidence it serves as a therapeutic target, interacts with drugs, or has clinical biomarker utility. Its presence reflects ribosomal RNA gene expansion and evolutionary processes in eukaryotic genomes. Key Points: - Not a therapeutic target: As a pseudogene, it is non-functional and not considered a target for drugs or therapies[2][8]. - Non-coding and non-functional: Unlike 5S ribosomal RNA genes that function in ribosomal assembly and protein synthesis, pseudogenes have lost that function through mutation or genomic rearrangement[2][5][8]. - Incorrect for therapeutic use: The query is "incorrect" in the context of drug targeting or biomarker identification, and any roles listed for ribosomal pseudogenes in therapeutic targeting are unsupported at present[2][8]. - No known disease or drug relevance: Current evidence suggests ribosomal RNA pseudogenes are not associated with disease mechanisms, drug interactions, or direct biological functions beyond evolutionary marking[6]. Structured summary: This entry describes a non-coding RNA pseudogene, not a receptor, enzyme, or other classical therapeutic target. It has no established biological, biomarker, or safety role, and is not suitable for clinical targeting or structured drug interaction data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 380 (RNA5SP380).